H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)

September 18, 2026 6:48 AM

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Neutral rating and $1.50 price target on Aethlon Medical (NASDAQ: AEMD).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found